Advertisement

Heart Failure Reviews

, Volume 23, Issue 2, pp 209–223 | Cite as

Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis

  • M. J. Pearson
  • S. F. Mungovan
  • N. A. Smart
Article

Abstract

Elevated levels of pro-inflammatory markers are evident in patients with heart failure and are associated with disease severity and prognosis. Exercise training has been shown to reduce circulating levels of pro-inflammatory cytokines and other pro-inflammatory markers in healthy and clinical populations. The aim of the systematic review and meta-analysis was to investigate the effect of aerobic (AT) and resistance training (RT) interventions on circulating concentrations of inflammatory markers; tumour necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), C-reactive protein (CRP), fibrinogen, soluble intercellular adhesion molecule (sICAM) and soluble vascular adhesion molecule (sVCAM) in heart failure patients. We conducted database searches (PubMed, EMBASE and Cochrane Trials Register to 30 June 2017) for exercise-based trials in heart failure, using the following search terms: exercise training, inflammation, tumour necrosis factor-alpha, interleukin 6, C-reactive protein, fibrinogen, soluble intercellular adhesions molecule-1, soluble vascular adhesion molecule-1. Twenty studies, representing 18 independent trials, were included in the review. Pooled data of six studies indicated a minimally favourable effect of exercise training on circulating TNF-α [SMD 0.42 (95% CI 0.15, 0.68), p = 0.002)]. However, together the pooled and descriptive analyses failed to provide strong evidence for a reduction in other pro-inflammatory markers. However, given the complexity of heart failure and the pathways involved in the immune and inflammatory process, large prospective trials considering aetiology, comorbidities and local skeletal muscle inflammation are required to elucidate on the anti-inflammatory effect of exercise in this population.

Keywords

Heart failure Inflammatory markers TNF-α IL-6 CRP Fibrinogen sVCAM-1 sICAM-1 

Notes

Acknowledgements

M.J Pearson is supported by an Australian Postgraduate Award Scholarship. This work received no other financial support and has no relationship to industry.

Compliance with ethical standards

Conflict of interest

The authors report no relationships that could be construed as a conflict of interest.

Supplementary material

10741_2018_9677_MOESM1_ESM.docx (54 kb)
ESM 1 (DOCX 53 kb)
10741_2018_9677_MOESM2_ESM.docx (47 kb)
ESM 2 (DOCX 47 kb)

References

  1. 1.
    Dick SA, Epelman S (2016) Chronic heart failure and inflammation. Circ Res 119(1):159–176.  https://doi.org/10.1161/CIRCRESAHA.116.308030 CrossRefPubMedGoogle Scholar
  2. 2.
    Briasoulis A, Androulakis E, Christophides T, Tousoulis D (2016) The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure. Heart Fail Rev 21(2):169–176.  https://doi.org/10.1007/s10741-016-9533-z CrossRefPubMedGoogle Scholar
  3. 3.
    Van Linthout S, Tschöpe C (2017) Inflammation—cause or consequence of heart failure or both? Curr Heart Fail Rep 14(4):251–265.  https://doi.org/10.1007/s11897-017-0337-9 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction. J Am Coll Cardiol 62(4):263–271.  https://doi.org/10.1016/j.jacc.2013.02.092 CrossRefPubMedGoogle Scholar
  5. 5.
    Shirazi LF, Bissett J, Romeo F, Mehta JL (2017) Role of inflammation in heart failure. Curr Atheroscler Rep 19(6):27CrossRefPubMedGoogle Scholar
  6. 6.
    Hartupee J, Mann DL (2013) Positioning of inflammatory biomarkers in the heart failure landscape. J Cardiovasc Transl Res 6(4):485–492.  https://doi.org/10.1007/s12265-013-9467-y CrossRefPubMedGoogle Scholar
  7. 7.
    Smart NA, Steele M (2011) The effect of physical training on systemic proinflammatory cytokine expression in heart failure patients: a systematic review. Congest Heart Fail 17(3):110–114.  https://doi.org/10.1111/j.1751-7133.2011.00217.x CrossRefPubMedGoogle Scholar
  8. 8.
    Medzhitov R (2010) Inflammation 2010: new adventures of an old flame. Cell 140(6):771–776.  https://doi.org/10.1016/j.cell.2010.03.006 CrossRefPubMedGoogle Scholar
  9. 9.
    Lavine KJ, Sierra OL (2017) Skeletal muscle inflammation and atrophy in heart failure. Heart Fail Rev 22(2):179–189.  https://doi.org/10.1007/s10741-016-9593-0 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Adams V, Linke A, Winzer E (2017) Skeletal muscle alterations in HFrEF vs. HFpEF. Curr Heart Fail Rep 1–9Google Scholar
  11. 11.
    Yndestad A, Damås JK, Øie E, Ueland T, Gullestad L, Aukrust P (2006) Systemic inflammation in heart failure—the whys and wherefores. Heart Fail Rev 11(1):83–92.  https://doi.org/10.1007/s10741-006-9196-2 CrossRefPubMedGoogle Scholar
  12. 12.
    Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323(4):236–241.  https://doi.org/10.1056/NEJM199007263230405 CrossRefPubMedGoogle Scholar
  13. 13.
    Beavers KM, Brinkley TE, Nicklas BJ (2010) Effect of exercise training on chronic inflammation. Clin Chim Acta 411(11):785–793.  https://doi.org/10.1016/j.cca.2010.02.069 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Fedewa MV, Hathaway ED, Ward-Ritacco CL (2016) Effect of exercise training on C reactive protein: a systematic review and meta-analysis of randomised and non-randomised controlled trials. Br J Sports Med. bjsports-2016-095999Google Scholar
  15. 15.
    Pedersen BK (2017) Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Investig 47(8):600–611.  https://doi.org/10.1111/eci.12781 CrossRefGoogle Scholar
  16. 16.
    Hammonds TL, Gathright EC, Goldstein CM, Penn MS, Hughes JW (2016) Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: a meta-analysis. Heart Lung 45(3):273–282.  https://doi.org/10.1016/j.hrtlng.2016.01.009 CrossRefPubMedGoogle Scholar
  17. 17.
    Kasapis C, Thompson PD (2005) The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 45(10):1563–1569.  https://doi.org/10.1016/j.jacc.2004.12.077 CrossRefPubMedGoogle Scholar
  18. 18.
    Ponikowski P, Voors AA, Anker SD et al (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37(27):2129–2200mCrossRefPubMedGoogle Scholar
  19. 19.
    Adamopoulos S, Parissis J, Karatzas D et al (2002) Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 39(4):653–663CrossRefPubMedGoogle Scholar
  20. 20.
    Larsen AI, Aukrust P, Aarsland T, Dickstein K (2001) Effect of aerobic exercise training on plasma levels of tumor necrosis factor alpha in patients with heart failure. Am J Cardiol 88(7):805–808.  https://doi.org/10.1016/S0002-9149(01)01859-8 CrossRefPubMedGoogle Scholar
  21. 21.
    Adamopoulos S, Parissis J, Kroupis C et al (2001) Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22(9):791–797CrossRefPubMedGoogle Scholar
  22. 22.
    Parrinello G, Torres D, Paterna S, Di Pasquale P, Trapanese C, Licata G (2010) Short-term walking physical training and changes in body hydration status, B-type natriuretic peptide and C-reactive protein levels in compensated congestive heart failure. Int J Cardiol 144(1):97–100.  https://doi.org/10.1016/j.ijcard.2008.12.130 CrossRefPubMedGoogle Scholar
  23. 23.
    Ahmad T, Fiuzat M, Mark DB et al (2014) The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure. Am Heart J 167(2):193–202.e191CrossRefPubMedGoogle Scholar
  24. 24.
    Smart NA, Larsen AI, Le Maitre JP, Ferraz AS (2011) Effect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failure. Cardiol Res Pract 1(1)Google Scholar
  25. 25.
    Lee CT, Chen LW, Chien MY (2017) Effects of exercise training on anabolic and catabolic markers in patients with chronic heart failure: a systematic review. Heart Fail Rev 1–8Google Scholar
  26. 26.
    Fernandes-Silva MM, Guimarães GV, Rigaud VOC, Lofrano-Alves MS, Castro RE, de Barros Cruz LG, Bocchi EA, Bacal F (2017) Inflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: insights from a randomized clinical trial. Eur J Prev Cardiol 24(8):808–817.  https://doi.org/10.1177/2047487317690458 CrossRefPubMedGoogle Scholar
  27. 27.
    Savic-Radojevic A, Radovanovic S, Pekmezovic T et al (2013) The role of serum VCAM-1 and TNF-α as predictors of mortality and morbidity in patients with chronic heart failure. J Clin Lab Anal 27(2):105–112CrossRefPubMedGoogle Scholar
  28. 28.
    Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Lin SJ, Young MS (2003) The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure. Eur J Heart Fail 5(4):507–516.  https://doi.org/10.1016/S1388-9842(03)00009-6 CrossRefPubMedGoogle Scholar
  29. 29.
    Araújo JP, Lourenço P, Azevedo A et al (2009) Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 15(3):256–266CrossRefPubMedGoogle Scholar
  30. 30.
    Mongirdienė A, Kubilius R (2015) Effect of physical training on indices of platelet aggregation and fibrinogen concentration in patients with chronic heart failure. Medicina (Kaunas, Lithuania) 51(6):343–350CrossRefGoogle Scholar
  31. 31.
    Fu R, Vandermeer BW, Shamliyan TA, et al. Handling continuous outcomes in quantitative synthesis. 2013Google Scholar
  32. 32.
    Cohen J (1988) Statistical analysis for the behavioral sciences. Hillsdale, Lawrance ErlbaumGoogle Scholar
  33. 33.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560.  https://doi.org/10.1136/bmj.327.7414.557 CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634.  https://doi.org/10.1136/bmj.315.7109.629 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Smart NA, Waldron M, Ismail H et al (2015) Validation of a new tool for the assessment of study quality and reporting in exercise training studies: TESTEX. Int J Evid Based Healthc 13(1):9–18CrossRefPubMedGoogle Scholar
  36. 36.
    de Meirelles LR, Matsuura C, Resende Ade C et al (2014) Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients. Eur J Prev Cardiol 21(10):1225–1232CrossRefPubMedGoogle Scholar
  37. 37.
    Trippel TD, Holzendorf V, Halle M et al (2017) Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study. ESC Heart Fail 4(1):56–65CrossRefPubMedGoogle Scholar
  38. 38.
    Aksoy S, Findikoglu G, Ardic F, Rota S, Dursunoglu D (2015) Effect of 10-week supervised moderate-intensity intermittent vs. continuous aerobic exercise programs on vascular adhesion molecules in patients with heart failure. Am J Phys Med Rehabil Assoc Acad Physiatrists 94(10):898–911.  https://doi.org/10.1097/PHM.0000000000000306 CrossRefGoogle Scholar
  39. 39.
    Kitzman DW, Brubaker P, Morgan T et al (2016) Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 315(1):36–46CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Fu TC, Wang CH, Lin PS et al (2013) Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol 167(1):41–50.  https://doi.org/10.1016/j.ijcard.2011.11.086 CrossRefPubMedGoogle Scholar
  41. 41.
    Wisløff U, Støylen A, Loennechen JP et al (2007) Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation 115(24):3086–3094CrossRefPubMedGoogle Scholar
  42. 42.
    Sandri M, Viehmann M, Adams V et al (2016) Chronic heart failure and aging—effects of exercise training on endothelial function and mechanisms of endothelial regeneration: results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study. Eur J Prev Cardiol 23(4):349–358CrossRefPubMedGoogle Scholar
  43. 43.
    Feiereisen P, Vaillant M, Gilson G, Delagardelle C (2013) Effects of different training modalities on circulating anabolic/catabolic markers in chronic heart failure. J Cardiopulm Rehabil Prev 33(5):303–308.  https://doi.org/10.1097/HCR.0b013e3182a1e4e5 CrossRefPubMedGoogle Scholar
  44. 44.
    Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011) Inflammatory markers and disease severity in patients with chronic heart failure. Limited effects of exercise training. Atheroscler Suppl 12(1):66.  https://doi.org/10.1016/S1567-5688(11)70308-7 CrossRefGoogle Scholar
  45. 45.
    Eleuteri E, Mezzani A, Di Stefano A et al (2013) Aerobic training and angiogenesis activation in patients with stable chronic heart failure: a preliminary report. Biomarkers 18(5):418–424CrossRefPubMedGoogle Scholar
  46. 46.
    Erbs S, Höllriegel R, Linke A et al (2010) Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail 3(4):486–494CrossRefPubMedGoogle Scholar
  47. 47.
    Gielen S, Adams V, Möbius-Winkler S et al (2003) Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42(5):861–868CrossRefPubMedGoogle Scholar
  48. 48.
    Linke A, Adams V, Schulze PC et al (2005) Antioxidative effects of exercise training in patients with chronic heart failure. Circulation 111(14):1763–1770CrossRefPubMedGoogle Scholar
  49. 49.
    Tsarouhas K, Tsitsimpikou C, Haliassos A et al (2011) Study of insulin resistance, TNF-alpha, total antioxidant capacity and lipid profile in patients with chronic heart failure under exercise. In Vivo 25(6):1031–1037PubMedGoogle Scholar
  50. 50.
    Helmy ZM, Mohammed SH, Soliman GS Effect of resisted exercise training on interleukin-6 in patients with chronic heart failureGoogle Scholar
  51. 51.
    Conraads VM, Beckers P, Bosmans J, de Clerck LS, Stevens WJ, Vrints CJ, Brutsaert DL (2002) Combined endurance/resistance training reduces plasma TNF-alpha receptor levels in patients with chronic heart failure and coronary artery disease. Eur Heart J 23(23):1854–1860.  https://doi.org/10.1053/euhj.2002.3239 CrossRefPubMedGoogle Scholar
  52. 52.
    Gielen S, Sandri M, Kozarez I, et al. Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging (LEICA) catabolism study. Circulation. 2012:CIRCULATIONAHA. 111.047381Google Scholar
  53. 53.
    Davalos D, Akassoglou K (2012) Fibrinogrn as a key regulator of inflammation in disease. Paper presented at. Semin ImmunopatholGoogle Scholar
  54. 54.
    Hayashino Y, Jackson JL, Hirata T, Fukumori N, Nakamura F, Fukuhara S, Tsujii S, Ishii H (2014) Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 63(3):431–440.  https://doi.org/10.1016/j.metabol.2013.08.018 CrossRefPubMedGoogle Scholar
  55. 55.
    Canada JM, Fronk DT, Cei LF et al (2016) Usefulness of C-reactive protein plasma levels to predict exercise intolerance in patients with chronic systolic heart failure. Am J Cardiol 117(1):116–120.  https://doi.org/10.1016/j.amjcard.2015.10.020 CrossRefPubMedGoogle Scholar
  56. 56.
    Chin B, Blann A, Gibbs C, Chung N, Conway D, Lip G (2003) Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Investig 33(11):941–948.  https://doi.org/10.1046/j.1365-2362.2003.01252.x CrossRefGoogle Scholar
  57. 57.
    Kato M, Masuda T, Ogano M et al (2017) Stretching exercises improve vascular endothelial dysfunction through attenuation of oxidative stress in chronic heart failure patients with an implantable cardioverter defibrillator. J Cardiopulm Rehabil Prev 37(2):130–138CrossRefPubMedGoogle Scholar
  58. 58.
    Swardfager W, Herrmann N, Cornish S et al (2012) Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysis. Am Heart J 163(4):666–676. e663CrossRefPubMedGoogle Scholar
  59. 59.
    Bjornstad HH, Bruvik J, Bjornstad AB, Hjellestad BL, Damas JK, Aukrust P (2008) Exercise training decreases plasma levels of soluble CD40 ligand and P-selectin in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 15(1):43–48.  https://doi.org/10.1097/HJR.0b013e3281ca7023 CrossRefPubMedGoogle Scholar
  60. 60.
    Karavidas AI, Raisakis KG, Parissis JT et al (2006) Functional electrical stimulation improves endothelial function and reduces peripheral immune responses in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 13(4):592–597.  https://doi.org/10.1097/01.hjr.0000219111.02544.ff CrossRefPubMedGoogle Scholar
  61. 61.
    Pearson M, Smart N (2017) Effect of exercise training on endothelial function in heart failure patients: a systematic review meta-analysis. Int J Cardiol 231:234–243.  https://doi.org/10.1016/j.ijcard.2016.12.145 CrossRefPubMedGoogle Scholar
  62. 62.
    Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA (2011) The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11(9):607–615.  https://doi.org/10.1038/nri3041 CrossRefPubMedGoogle Scholar
  63. 63.
    Sallam N, Laher I (2016) Exercise modulates oxidative stress and inflammation in aging and cardiovascular diseases. Oxidative Med Cell Longev 2016:1–32.  https://doi.org/10.1155/2016/7239639 CrossRefGoogle Scholar
  64. 64.
    Ihalainen J, Schumann M, Eklund D et al (2017) Combined aerobic and resistance training decreases inflammation markers in healthy men. Scand J Med Sci SportsGoogle Scholar
  65. 65.
    Nimmo M, Leggate M, Viana J, King J (2013) The effect of physical activity on mediators of inflammation. Diabetes Obes Metab 15(s3):51–60.  https://doi.org/10.1111/dom.12156 CrossRefPubMedGoogle Scholar
  66. 66.
    Theodorou AA, Panayiotou G, Volaklis KA et al (2016) Aerobic, resistance and combined training and detraining on body composition, muscle strength, lipid profile and inflammation in coronary artery disease patients. Res Sports Med 24(3):171–184CrossRefPubMedGoogle Scholar
  67. 67.
    Balducci S, Zanuso S, Nicolucci A et al (2010) Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 20(8):608–617CrossRefPubMedGoogle Scholar
  68. 68.
    Fedewa MV, Hathaway ED, Higgins S, Forehand RL, Schmidt MD, Evans EM (2017) Moderate, but not vigorous, intensity exercise training reduces C-reactive protein. Acta Cardiol 1–8.  https://doi.org/10.1080/00015385.2017.1364832
  69. 69.
    Cronin O, Keohane DM, Molloy MG, Shanahan F (2017) The effect of exercise interventions on inflammatory biomarkers in healthy, physically inactive subjects: a systematic review. QJM Int J Med hcx091Google Scholar
  70. 70.
    Lin X, Zhang X, Guo J et al (2015) Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc 4(7):e002014CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    van Empel V, Brunner-La Rocca H-P (2015) Inflammation in HFpEF: key or circumstantial? Int J Cardiol 189:259–263.  https://doi.org/10.1016/j.ijcard.2015.04.110 CrossRefPubMedGoogle Scholar
  72. 72.
    Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135.  https://doi.org/10.1186/1471-2288-14-135 CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Parkitny L, McAuley JH, Kelly PJ, Di Pietro F, Cameron B, Moseley GL (2013) Multiplex cytokine concentration measurement: how much do the medium and handling matter? Mediat Inflamm 2013:1–13.  https://doi.org/10.1155/2013/890706 CrossRefGoogle Scholar
  74. 74.
    Bonsu KO, Reidpath DD, Kadirvelu A (2015) Effects of statin treatment on inflammation and cardiac function in heart failure: an adjusted indirect comparison meta-analysis of randomized trials. Cardiovasc Ther 33(6):338–346.  https://doi.org/10.1111/1755-5922.12150 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Science and TechnologyUniversity of New EnglandArmidaleAustralia
  2. 2.Westmead Private Physiotherapy Services and The Clinical Research InstituteSydneyAustralia
  3. 3.Department of Physiotherapy, Faculty of Medicine, Dentistry and Health SciencesThe University of MelbourneMelbourneAustralia

Personalised recommendations